Terms: = Gastric cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
24 results:
1. The Naples Prognostic Score Is an Independent Prognostic Factor for gastric cancer Patients Who Receive Curative treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract] [Full Text] [Related]
2. Effects of Extended Fixation on Advanced gastric cancer HER2 Status Assessment Using IHC and FISH.
Kondo J; Yoshino S; Iida M; Takeda S; Nakashima C; Watanabe Y; Nishiyama M; Tokumitsu Y; Shindo Y; Nishimura T; Suzuki N; Hoshii Y; Itoh H; Nagano H
Anticancer Res; 2024 Feb; 44(2):621-630. PubMed ID: 38307565
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
Wei C; Ma Y; Wang F; Chen Y; Liao Y; Zhao B; Zhao Q; Tang D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15561-15572. PubMed ID: 37648811
[TBL] [Abstract] [Full Text] [Related]
4. Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
Zhang L; Wang W; Ge S; Li H; Bai M; Duan J; Yang Y; Ning T; Liu R; Wang X; Ji Z; Wang F; Zhang H; Ba Y; Deng T
BMC Cancer; 2023 Mar; 23(1):211. PubMed ID: 36872337
[TBL] [Abstract] [Full Text] [Related]
5. The necessarity of treatment for small gastric subepithelial tumors (1-2 cm) originating from muscularis propria: an analysis of 972 tumors.
Hu J; Sun X; Ge N; Wang S; Guo J; Liu X; Wang G; Sun S
BMC Gastroenterol; 2022 Apr; 22(1):182. PubMed ID: 35410177
[TBL] [Abstract] [Full Text] [Related]
6. [A comparative study on short-term outcomes and quality of life for gastric cancer patients between totally laparoscopic total gastrectomy using an endoscopic linear stapler and laparoscopic-assisted total gastrectomy using a circular stapler].
Hu P; Liang WQ; Xi HQ; Zhang KC; Cui JX; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):157-165. PubMed ID: 35176828
[No Abstract] [Full Text] [Related]
7. Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients.
Lu H; Sun Y; Zhu Z; Xu H; Huang R; Huang B
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1329-1336. PubMed ID: 34431734
[TBL] [Abstract] [Full Text] [Related]
8. Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study.
Adelborg K; Farkas DK; Sundbøll J; Schapira L; Tamang S; Cullen MR; Cronin-Fenton D; Sørensen HT
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32611556
[TBL] [Abstract] [Full Text] [Related]
9. The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study.
Shen M; Xia R; Luo Z; Zeng H; Wei W; Zhuang G; Zhang L; Chen W
J Theor Biol; 2020 Jan; 484():109996. PubMed ID: 31491497
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence and initial prescription of psychotropics in patients with common cancers in Japan, based on a nationwide health insurance claims database.
Sato I; Onishi H; Yamada S; Kawakami K
Psychooncology; 2018 Feb; 27(2):450-457. PubMed ID: 28750146
[TBL] [Abstract] [Full Text] [Related]
11. Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003).
Tanaka H; Kanda M; Morita S; Taguri M; Nishikawa K; Shimada M; Muguruma K; Koeda K; Takahashi M; Nakamori M; Konno H; Tsuji A; Hosoya Y; Shirasaka T; Yamamitsu S; Sowa M; Kitajima M; Okajima M; Kobayashi M; Sakamoto J; Saji S; Hirakawa K
Int J Clin Oncol; 2017 Dec; 22(6):1052-1059. PubMed ID: 28667408
[TBL] [Abstract] [Full Text] [Related]
12. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
13. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.
Fuse N; Bando H; Chin K; Ito S; Yoshikawa T; Tsuburaya A; Terashima M; Kawashima Y; Fukunaga T; Gotoh M; Emi Y; Yoshida K; Oki E; Takahashi S; Kuriki H; Sato K; Sasako M
Gastric Cancer; 2017 Mar; 20(2):332-340. PubMed ID: 26956689
[TBL] [Abstract] [Full Text] [Related]
14. S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic gastric cancer: A Randomized, Open-Label Phase 2 Trial.
Du F; Zheng Z; Shi S; Jiang Z; Qu T; Yuan X; Sun Y; Song Y; Yang L; Zhao J; Wang J; Chi Y
Medicine (Baltimore); 2015 Jun; 94(23):e958. PubMed ID: 26061330
[TBL] [Abstract] [Full Text] [Related]
15. Endoscopic submucosal dissection for early gastric cancer with undifferentiated-type histology: A meta-analysis.
Bang CS; Baik GH; Shin IS; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ; Shin WG; Kim KH; Kim HY; Lim H; Kang HS; Kim JH; Kim JB; Jung SW; Kae SH; Jang HJ; Choi MH
World J Gastroenterol; 2015 May; 21(19):6032-43. PubMed ID: 26019470
[TBL] [Abstract] [Full Text] [Related]
16. Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Morris KT; Nofchissey RA; Pinchuk IV; Beswick EJ
PLoS One; 2014; 9(6):e98656. PubMed ID: 24887129
[TBL] [Abstract] [Full Text] [Related]
17. Milatuzumab-SN-38 conjugates for the treatment of cd74+ cancers.
Govindan SV; Cardillo TM; Sharkey RM; Tat F; Gold DV; Goldenberg DM
Mol Cancer Ther; 2013 Jun; 12(6):968-78. PubMed ID: 23427296
[TBL] [Abstract] [Full Text] [Related]
18. cd74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract] [Full Text] [Related]
19. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer.
Wan C; Meng Q; Yang Z; Tu X; Feng C; Tang X; Zhang C
Ann Oncol; 2008 Dec; 19(12):2053-60. PubMed ID: 18653703
[TBL] [Abstract] [Full Text] [Related]
20. cd74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract] [Full Text] [Related]
[Next]
